Chimerix Inc (NASDAQ:CMRX)

5.04
Delayed Data
As of Apr 24
 +0.05 / +1.00%
Today’s Change
4.17
Today|||52-Week Range
6.24
+8.86%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$271.1M

Company Description

Chimerix, Inc. engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes Brincidofovir for the treatment of adenovirus, cytomegalovirus, and smallpox. The company was founded by George R. Painter, III and Timothy Wollaeger in April 2000 and is headquartered in Durham, NC.

Contact Information

Chimerix, Inc.
2505 Meridian Parkway
Durham North Carolina 27713
P:(919) 806-1074
Investor Relations:
(919) 287-4125

Employees

Shareholders

Other institutional44.79%
Mutual fund holders30.73%
Individual stakeholders18.87%

Top Executives

M. Michelle BerreyPresident, Chief Executive Officer & Director
Timothy W. TrostChief Financial Officer, Secretary & Senior VP
Joseph F. RutledgeChief Information Officer & VP-IT
William Garrett NicholsChief Medical Officer
Randall LanierChief Science Officer